SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-21-005814
Filing Date
2021-03-11
Accepted
2021-03-11 16:21:52
Documents
106
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 2415451
2 ex4-2.htm EX-4.2 21204
3 ex10-15.htm EX-10.15 54741
4 ex21-1.htm EX-21.1 5822
5 ex23-1.htm EX-23.1 3926
6 ex31-1.htm EX-31.1 18176
7 ex32-1.htm EX-32.1 6932
8 form10-k_001.jpg GRAPHIC 12253
9 form10-k_002.jpg GRAPHIC 18812
10 form10-k_003.jpg GRAPHIC 12639
11 form10-k_004.jpg GRAPHIC 11595
  Complete submission text file 0001493152-21-005814.txt   10901216

Data Files

Seq Description Document Type Size
12 XBRL SCHEMA FILE lctx-20201231.xsd EX-101.SCH 98352
13 XBRL CALCULATION FILE lctx-20201231_cal.xml EX-101.CAL 87754
14 XBRL DEFINITION FILE lctx-20201231_def.xml EX-101.DEF 422352
15 XBRL LABEL FILE lctx-20201231_lab.xml EX-101.LAB 692713
16 XBRL PRESENTATION FILE lctx-20201231_pre.xml EX-101.PRE 556930
17 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 1544101
Mailing Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008
Business Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008 5105213390
Lineage Cell Therapeutics, Inc. (Filer) CIK: 0000876343 (see all company filings)

IRS No.: 943127919 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-12830 | Film No.: 21733589
SIC: 2836 Biological Products, (No Diagnostic Substances)